Downloads
Revenue

Description

CSCO APP由中国临床肿瘤学会推出的一款为CSCO用户提供在线学习、参加会议、获取专业信息的学术性产品。
主要功能包括:
1.学术会议:用户可在线注册参会,同时可进行会议日程查询以及设置日程提醒等。
2.直播专区:提供学术会议及专家讲堂直播服务,无需亲临现场,学术内容尽在掌握之中。

Screenshots

CSCO FAQ

  • Is CSCO free?

    Yes, CSCO is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is CSCO legit?

    ⚠️ The CSCO app has poor ratings and negative feedback. Users seem unsatisfied with its performance or features.

    Thanks for the vote

  • How much does CSCO cost?

    CSCO is free.

  • What is CSCO revenue?

    To get estimated revenue of CSCO app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Russia yet.
Ratings History

CSCO Reviews

太差劲了

秋风落叶云中君 on

China

无限完善个人信息无法登陆,这么个行业大会软件怎么搞的这么垃圾

无限完善个人信息后的无法进入

查干夫 on

China

如题

强制更新,不更新就用不了,这都什么年代了,还来这招,讨厌到极点了

讨厌的app更新 on

China

这都什么年代了,还来这招,讨厌到极点了

用不了了????

几妹 on

China

什么情况

没有最烂,只有更烂

御影.风 on

China

这APP太难用了,各种bug

实用性很强,能学习很多知识,但是从去年年底以来,不断的出现故障,无法正常使用,希望能尽快维护好

微笑842 on

China

实用性很强,能学习很多知识,但是从去年年底以来,不断的出现故障,无法正常使用,希望能尽快维护好

完全无法使用了。

天之流星 on

China

从12月底开始就无法显示个人信息和会议视频了,望尽快解决。

更新之后用不了了

lanmeimeiwang on

China

更新之后用不了了更新之后用不了了更新之后用不了了

求助

doctor-hua on

China

如何边看ppt边听演讲?

很辣鸡的APP,大概大家都是为了参会才下载吧

人好多挤死了 on

China

很辣鸡的APP,大概大家都是为了参会才下载吧

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet

Keywords

CSCO Competitors

Name
梅斯医学 - 医路相伴,成就大医
大专家医生版
良医汇-肿瘤医生
肿瘤化疗助手
TalkMED
医路有伴-专业的医疗外科教学平台
海心医生
肿瘤指南者医生端
乐问医学
乐问医学-做大数据+AI与生命科学的链接者
药研社

CSCO Installs

Last 30 days

CSCO Revenue

Last 30 days

CSCO Revenue and Downloads

Gain valuable insights into CSCO performance with our analytics.
Sign up now to access downloads, revenue, and more.
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.